WCLC 2023 Insights: "ILLUMINATE - Efficacy & Safety of Durvalumab-Tremelimumab & Chemotherapy in EGFRm NSCLC Following Progression on EGFR Inhibitors" | VuMedi

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

10 seconds

Playback speed

Insights from 2023 WCLC

WCLC 2023 Insights: "ILLUMINATE - Efficacy & Safety of Durvalumab-Tremelimumab & Chemotherapy in EGFRm NSCLC Following Progression on EGFR Inhibitors"

By Insights from 2023 WCLC FEATURING Chee Khoon Lee

By Insights from 2023 WCLC FEATURING Chee Khoon Lee

89 views

September 22, 2023

Comments 0

Login to view comments. Click here to Login